Zobrazeno 1 - 10
of 21
pro vyhledávání: '"C K, Tebbi"'
Autor:
G, Karayalcin, F G, Behm, P W, Gieser, F, Kung, M, Weiner, C K, Tebbi, C, Ferree, R, Marcus, L, Constine, N P, Mendenhall, A, Chauvenet, S B, Murphy
Publikováno v:
Medical and pediatric oncology. 29(6)
In this report, the Pediatric Oncology Group (POG) experience with lymphocyte predominant Hodgkin Disease (LPHD) in children is reviewed.From 1984-1993, the POG conducted 3 clinical trials for advanced stage HD and 2 for early stage HD. There were 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::daf7acf531139dd7a58d5d7761af6b66
https://pubmed.ncbi.nlm.nih.gov/9324338
https://pubmed.ncbi.nlm.nih.gov/9324338
Autor:
G H, Reaman, J, Bonfiglio, M, Krailo, C K, Tebbi, S, Leikin, R, Ettinger, L K, Zeltzer, J B, Nachman, G K, Rivera, A, Aboulafia
Publikováno v:
Cancer. 71
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce0981197a8bae7d9165a0be870ec407
https://pubmed.ncbi.nlm.nih.gov/8490852
https://pubmed.ncbi.nlm.nih.gov/8490852
Autor:
C K, Tebbi
Publikováno v:
Cancer. 71
Experience reveals that there is significant noncompliance with self-administered medication, especially in chronic conditions such as cancer. Noncompliance transcends the boundary of disease categories and age group. However, this is most prevalent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::630a4d83ca03c28e34fd82a58bc6cecf
https://pubmed.ncbi.nlm.nih.gov/8490895
https://pubmed.ncbi.nlm.nih.gov/8490895
Autor:
L H, Baker, J, Jones, A, Stovall, L K, Zeltzer, S P, Heiney, L, Sensenbrenner, C K, Tebbi, E J, Spoerl, D, Zook
Publikováno v:
Cancer. 71(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5d1317f1ec9eef95c6a3f13371ff16a
https://pubmed.ncbi.nlm.nih.gov/8453564
https://pubmed.ncbi.nlm.nih.gov/8453564
Autor:
C K, Tebbi
Publikováno v:
Cancer treatment and research. 62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6871b94620f949b84e30d9a1b0b0db6a
https://pubmed.ncbi.nlm.nih.gov/8096757
https://pubmed.ncbi.nlm.nih.gov/8096757
Publikováno v:
Cancer. 66(10)
Experience with high-dose cytosine arabinoside (HDAC) in pediatric solid tumors is limited. Sixteen children with solid tumors resistant to conventional therapies were registered in a pilot Pediatric Oncology Group (POG) study that required the admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6b45d4025cd53d02a04481bb7a545ff
https://pubmed.ncbi.nlm.nih.gov/2224760
https://pubmed.ncbi.nlm.nih.gov/2224760
Publikováno v:
The Journal of Immunology. 132:2089-2095
We generated a monoclonal antibody, termed SN2, which defines a human T cell leukemia-associated cell surface glycoprotein, GP37, with an approximate m.w. of 37,000. This antibody was generated by using a human leukemia antigen preparation. The react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::713822b10b7a92121ed45901698ed645
https://doi.org/10.4049/jimmunol.132.4.2089
https://doi.org/10.4049/jimmunol.132.4.2089
Autor:
C. K. Tebbi, A. I. Freeman
Publikováno v:
Pediatrics in Review. 6:55-62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfc2a2b200f5df3e4e2d2cf9e7f5e24f
https://doi.org/10.1542/pir.6-2-55
https://doi.org/10.1542/pir.6-2-55
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 132(4)
We generated a monoclonal antibody, termed SN2, which defines a human T cell leukemia-associated cell surface glycoprotein, GP37, with an approximate m.w. of 37,000. This antibody was generated by using a human leukemia antigen preparation. The react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d2cd4568f45d4bd57458b03f931b84ee
https://pubmed.ncbi.nlm.nih.gov/6607954
https://pubmed.ncbi.nlm.nih.gov/6607954
Publikováno v:
Clinical and experimental immunology. 60(3)
The specific cytotoxic activity of anti-human T cell leukaemia immunotoxins (IT) was investigated for their effects on in vitro colony formation of leukaemic cells and normal haematopoietic progenitors, i.e., CFU-GM, CFU-E and CFU-GEMM. These IT were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba708daedd121da41bef8783729fa3e0
https://pubmed.ncbi.nlm.nih.gov/3874727
https://pubmed.ncbi.nlm.nih.gov/3874727